Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(1)

Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]

1 trial

phase_2

european-organisation-for-research-and-treatment-of-cancer-eortc

1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT03620149Phase 2Terminated

Reduced Dose-density of Denosumab for Unresectable GCTB

Bone Giant Cell Tumor

StudychairStart date: 2019-09-26

Research Network

Collaboration Network

2 collaborators·1 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Bone Giant Cell Tumor1

Affiliations

IRCCS Instituto Ortopedico Rizzoli

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

1 similar investigators found

Hans Gelderblom

Leiden University Medical Center

1 trials

Shared therapeutic areas:

Bone Giant Cell Tumor

Worked with same sponsors:

AmgenEuropean Organisation for Research and Treatment of Cancer - EORTC

Collaborated on 1 trial

Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03620149Phase 2StudyChair

Reduced Dose-density of Denosumab for Unresectable GCTB

Bone Giant Cell Tumor

Terminated

All 1 trials loaded